Visceral arterial resection with interposition grafting for pancreatic cancer
Visceral arterial resection with interposition grafting for pancreatic cancer
Long-segment Barrett’s esophageal
Long-segment Barrett’s esophageal
Updates on the version 9
Updates on the version 9
Serum EV-MDM2 may be the first biomarker
Serum EV-MDM2 may be the first biomarker for retroperitoneal liposarcoma (RLS) recurrence. EV-MDM2 levels drop post-surgery but rise with recurrence. This can guide early detection and treatment decisions.